InMed Pharmaceuticals Inc.

NasdaqCM:INM Stock Report

Market Cap: US$3.2m

InMed Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:INM Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
31 Jul 24SellUS$42Alexandra ManciniIndividual12US$3.53
21 Feb 24BuyUS$14,625Andrew HullIndividual1,875US$7.80
20 Feb 24BuyUS$14,922Eric AdamsIndividual2,080US$7.17

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of INM?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders4,7230.658%
Institutions91,91312.8%
Hedge Funds116,50716.2%
General Public504,88970.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 173.3%.

Top Shareholders

Top 23 shareholders own 29.68% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.2%
Yorkville Advisors Global LP
80,372US$362.5k0%4.28%
5.11%
AdvisorShares Investments, LLC
36,664US$165.4k0%0.03%
5.03%
Sabby Management, LLC
36,135US$163.0k0%1.08%
4.85%
Armistice Capital LLC
34,816US$157.0k161%no data
1.48%
UBS Asset Management AG
10,601US$47.8k0%no data
0.39%
Citadel Advisors LLC
2,833US$12.8k369%no data
0.35%
Renaissance Technologies LLC
2,514US$11.3k0%no data
0.31%
Eric Adams
2,198US$9.9k0%no data
0.27%
Hudson River Trading LLC, Asset Management Arm
1,918US$8.7k140%no data
0.27%
Andrew Hull
1,913US$8.6k0%no data
0.2%
Virtu Financial LLC, Asset Management Arm
1,420US$6.4k-67.2%no data
0.16%
Baader Bank AG, Asset Management Arm
1,130US$5.1k0%no data
0.085%
Shane Johnson
609US$2.7k0%no data
0.00084%
BCV Asset Management
6US$27.20%no data
0.0007%
Bank of America Corporation, Asset Management Arm
5US$22.70%no data
0.00028%
Eric Hsu
2US$9.1-33.3%no data
0.00014%
RBC Dominion Securities Inc., Asset Management Arm
1US$4.50%no data
0.00014%
Fédération des Caisses Desjardins du Québec, Asset Management Arm
1US$4.50%no data
0.00014%
Osaic Wealth, Inc. , Asset Management Arm
1US$4.50%no data
0.00014%
Gables Capital Management Inc
1US$4.50%no data
0.00014%
AllSquare Wealth Management, LLC
1US$4.50%no data
0.00014%
Global Retirement Partners, LLC
1US$4.50%no data
0.00014%
Michael Woudenberg
1US$4.50%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 06:00
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

InMed Pharmaceuticals Inc. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullBrookline Capital Markets
Raghuram SelvarajuH.C. Wainwright & Co.
Jason McCarthyMaxim Group